Prices delayed by at least 15 minutes | Print
Hikma Pharmaceuticals PLC (HIK)
ORD SHS 10POpen
1,600.00p
Previous close
1,607.00p
Trade high
1,633.00p
Volume
267,491
Year high
1,865.00p
Year low
1,187.00p
Dividend yield
3.99%
Market capitalisation
£3.34 bn
P/E ratio
12.12
ISIN
GB00B0LCW083
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 20/03/2026 | 14/08/2026 |
| Ex-dividend date | 19/03/2026 | 13/08/2026 |
| Payment date | 30/04/2026 | 17/09/2026 |
| Amount | 35.29p | 29.09p |
Company profile
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority ofthe company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 09/10/2026 | 04:35:14 | 1612 | 162,256 | 2,615,566.72 |
| 09/10/2026 | 04:29:30 | 1611 | 24 | 386.64 |
| 09/10/2026 | 04:29:02 | 1613 | 9 | 145.17 |
| 09/10/2026 | 04:28:54 | 1612 | 59 | 951.08 |
| 09/10/2026 | 04:28:54 | 1612 | 1 | 16.12 |